FDA Panel Endorses New First-Line Lymphoma Regimen

(MedPage Today) -- Despite the concerns of FDA staff, agency advisors endorsed the inclusion of polatuzumab vedotin (Polivy) in a modified version of R-CHOP for adults with previously untreated large B-cell lymphoma. By a vote of 11-2 on Thursday...
Source: MedPage Today Public Health - Category: American Health Source Type: news